Michael Cloonan

Insider Reports History

Location
C/O Sage Therapeutics, Inc., 215 First Street, Cambridge, MA
Signature
Jennifer Fitzpatrick, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Michael Cloonan:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Sionna Therapeutics, Inc. President & CEO, Director Common Stock 547K $20.4M $37.31 Oct 21, 2025 Direct
bluebird bio, Inc. Director Common Stock 0 $0 $4.88 Jun 2, 2025 Direct
Sionna Therapeutics, Inc. President & CEO, Director Stock Option (Right to Buy) 450K Feb 6, 2025 Direct
bluebird bio, Inc. Director Stock Option (right to buy) 74.8K Jun 20, 2024 Direct
Sionna Therapeutics, Inc. President & CEO, Director Non-Qualified Stock Option (right to buy) 53.1K Oct 21, 2025 Direct

Insider Reports Filed by Michael Cloonan

Symbol Company Period Transactions Value $ Form Type Date Filed Role
SION Sionna Therapeutics, Inc. Oct 21, 2025 12 -$3.01M 4 Oct 22, 2025 President & CEO, Director
SION Sionna Therapeutics, Inc. Oct 15, 2025 9 -$634K 4 Oct 17, 2025 President & CEO, Director
SION Sionna Therapeutics, Inc. Sep 26, 2025 6 -$575K 4 Sep 30, 2025 President & CEO, Director
SION Sionna Therapeutics, Inc. Aug 26, 2025 6 -$472K 4 Aug 28, 2025 President & CEO, Director
SION Sionna Therapeutics, Inc. Aug 20, 2025 3 -$416K 4 Aug 21, 2025 President & CEO, Director
BLUE bluebird bio, Inc. Jun 2, 2025 1 $0 4 Jun 3, 2025 Director
SION Sionna Therapeutics, Inc. Feb 6, 2025 1 $0 4 Feb 10, 2025 President & CEO, Director
SION Sionna Therapeutics, Inc. Feb 6, 2025 0 $0 3 Feb 6, 2025 President & CEO, Director
BLUE bluebird bio, Inc. Sep 30, 2024 1 $0 4 Oct 2, 2024 Director
BLUE bluebird bio, Inc. Jun 20, 2024 1 $0 4 Jun 24, 2024 Director
BLUE bluebird bio, Inc. Jun 20, 2024 0 $0 3 Jun 24, 2024 Director